MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial

Phase 1

Completed

Conditions: CAD
Aging

Interventions: Drug: Rapamycin

First Posted Date: 2012-07-25

Last Posted Date: 2016-12-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 13

Registration Number: NCT01649960

Locations: 🇺🇸
Mayo Clinic in Rochester and Mayo Health System sites in Austin and Albert Lea, Minnesota, Rochester, Minnesota, United States

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2

Terminated

Conditions: Refractory Plasma Cell Myeloma

Interventions: Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Other: Laboratory Biomarker Analysis

First Posted Date: 2012-07-20

Last Posted Date: 2017-10-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 13

Registration Number: NCT01646762

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Prospective Use of Real-time MRI

Not Applicable

Completed

Conditions: Evaluate the Role of Real-time Imaging in Needle Placement
Evaluate the Workflow and Effectiveness of Realtime Imaging Versus Standard MR Imaging

Interventions: Procedure: Real-time imaging for MRI-guided procedures

First Posted Date: 2012-07-19

Last Posted Date: 2023-03-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1

Registration Number: NCT01644578

Locations: 🇺🇸
Mayo Clinic in Minnesota, Rochester, Minnesota, United States

Individualized Electronic Intervention to Promote Work Engagement

Not Applicable

Completed

Conditions: Resilience
Engagement at Work
Meaning in Work

Interventions: Behavioral: Electronic intervention suggesting behavioral activity

First Posted Date: 2012-07-18

Last Posted Date: 2013-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 288

Registration Number: NCT01643694

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Guided Self-Help for Functional Neurological Symptoms

Not Applicable

Terminated

Conditions: Functional Neurologic Disease

Interventions: Behavioral: Treatment As Usual
Behavioral: Guided Self-Help

First Posted Date: 2012-07-18

Last Posted Date: 2013-10-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 33

Registration Number: NCT01643161

Locations: 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States

Continous Positive Airway Pressure (CPAP) Compliance Study

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea (OSA)

Interventions: Behavioral: Standard of care
Behavioral: additional educational material

First Posted Date: 2012-07-17

Last Posted Date: 2013-03-07

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01642160

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients

Phase 1

Completed

Conditions: Eosinophilic Esophagitis

Interventions: Other: Absorbable sugars

First Posted Date: 2012-07-17

Last Posted Date: 2014-06-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT01641913

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Assessment of Coronary Plaque Composition Using Optical Coherence Tomography

Phase 1

Completed

Conditions: Coronary Small Vessel Disease
Coronary Atherosclerosis
Endothelial Dysfunction

Interventions: Device: Optical Coherence Tomography (C7 XR Dragonfly )

First Posted Date: 2012-07-17

Last Posted Date: 2016-10-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 41

Registration Number: NCT01642173

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Varenicline for Light Smokers

Phase 4

Completed

Conditions: Smoking

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2012-07-12

Last Posted Date: 2018-02-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 93

Registration Number: NCT01639560

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

ANX-042 Healthy Volunteer Dose Escalation Study

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: ANX-042
Drug: Placebo

First Posted Date: 2012-07-11

Last Posted Date: 2017-10-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT01638104

Locations: 🇺🇸
Celerion, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy